{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:34:05Z","timestamp":1768880045544,"version":"3.49.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/145955\/2019"],"award-info":[{"award-number":["SFRH\/BD\/145955\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021.07836.BD"],"award-info":[{"award-number":["2021.07836.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECIND\/00185\/2020"],"award-info":[{"award-number":["CEECIND\/00185\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MEC-RES\/0158\/2020"],"award-info":[{"award-number":["PTDC\/MEC-RES\/0158\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MEC-RES\/0158\/2020"],"award-info":[{"award-number":["PTDC\/MEC-RES\/0158\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MEC-RES\/0158\/2020"],"award-info":[{"award-number":["PTDC\/MEC-RES\/0158\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MEDOUT\/1112\/2021"],"award-info":[{"award-number":["PTDC\/MEDOUT\/1112\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECIND\/04058\/2018"],"award-info":[{"award-number":["CEECIND\/04058\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FCT and Stemmatters, Biotecnologia e Medicina Regenerativa SA","award":["PD\/BDE\/142978\/2018"],"award-info":[{"award-number":["PD\/BDE\/142978\/2018"]}]},{"name":"CUF D. Manuel de Mello grants"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pulmonary fibrosis (PF) represents the pathologic end stage of several interstitial lung diseases (ILDs) associated with high morbidity and mortality rates. However, current treatments can only delay disease progression rather than provide a cure. The role of inflammation in PF progression is well-established, but new insights into immune regulation are fundamental for developing more efficient therapies. c-MET signaling has been implicated in the migratory capacity and effector functions of immune cells. Nevertheless, the role of this signaling pathway in the context of PF-associated lung diseases remains unexplored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To determine the influence of c-MET in immune cells in the progression of pulmonary fibrosis, we used a conditional deletion of <jats:italic>c-Met<\/jats:italic> in immune cells. To induce pulmonary fibrosis mice were administered with bleomycin (BLM) intratracheally. Over the course of 21\u00a0days, mice were assessed for weight change, and after euthanasia at different timepoints, bronchoalveolar lavage fluid cells and lung tissue were assessed for inflammation and fibrosis. Furthermore, c-MET expression was assessed in cryobiopsy sections, bronchoalveolar lavage fluid cells samples and single cell RNA-sequencing dataset from human patients with distinct interstitial lung diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>c-MET expression was induced in lung immune cells, specifically in T cells, interstitial macrophages, and neutrophils, during the inflammatory phase of BLM-induced PF mouse model. Deletion of <jats:italic>c-Met<\/jats:italic> in immune cells correlated with earlier weight recovery and improved survival of BLM-treated mice. Moreover, the deletion of <jats:italic>c-Met<\/jats:italic> in immune cells was associated with early recruitment of the immune cell populations, normally found to express c-MET, leading to a subsequent attenuation of the cytotoxic and proinflammatory environment. Consequently, the less extensive inflammatory response, possibly coupled with tissue repair, culminated in less exacerbated fibrotic lesions. Furthermore, c-MET expression was up-regulated in lung T cells from patients with fibrosing ILD, suggesting a potential involvement of c-MET in the development of fibrosing disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results highlight the critical contribution of c-MET signaling in immune cells to their enhanced uncontrolled recruitment and activation toward a proinflammatory and profibrotic phenotype, leading to the exacerbation of lung injury and consequent development of fibrosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-024-02884-1","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T09:01:55Z","timestamp":1719046915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Catarina","family":"Barbosa-Matos","sequence":"first","affiliation":[]},{"given":"Caroline","family":"Borges-Pereira","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Lib\u00f3rio-Ramos","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Marcela","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Mendes-Frias","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Silvestre","sequence":"additional","affiliation":[]},{"given":"Nuno S.","family":"Os\u00f3rio","sequence":"additional","affiliation":[]},{"given":"H\u00e9lder N.","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Rita F.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Morais","sequence":"additional","affiliation":[]},{"given":"Massimiliano","family":"Mazzone","sequence":"additional","affiliation":[]},{"given":"Agostinho","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,6,22]]},"reference":[{"key":"2884_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cti2.1086","volume":"8","author":"A McLean-Tooke","year":"2019","unstructured":"McLean-Tooke A, Moore I, Lake F. Idiopathic and immune-related pulmonary fibrosis: diagnostic and therapeutic challenges. Clin Transl Immunol. 2019;8:1\u201315. https:\/\/doi.org\/10.1002\/cti2.1086.","journal-title":"Clin Transl Immunol"},{"key":"2884_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jinf.2020.02.017","volume":"80","author":"Y Xu","year":"2020","unstructured":"Xu Y, Dong J, An W, Lv X, Yin X, Zhang J-Z, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80:394\u2013400. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.017.","journal-title":"J Infect"},{"key":"2884_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1164\/rccm.201608-1675PP","volume":"196","author":"ML Salisbury","year":"2017","unstructured":"Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez FJ, Flaherty KR. Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go. Am J Respir Crit Care Med. 2017;196:690\u20139. https:\/\/doi.org\/10.1164\/rccm.201608-1675PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","volume":"10","author":"AU Wells","year":"2014","unstructured":"Wells AU, Denton CP. Interstitial lung disease in connective tissue disease\u2014mechanisms and management. Nat Rev Rheumatol. 2014;10:728\u201339. https:\/\/doi.org\/10.1038\/nrrheum.2014.149.","journal-title":"Nat Rev Rheumatol"},{"key":"2884_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/resp.12588","volume":"21","author":"V Cottin","year":"2016","unstructured":"Cottin V. Idiopathic interstitial pneumonias with connective tissue diseases features: a review. Respirology. 2016;21:245\u201358. https:\/\/doi.org\/10.1111\/resp.12588.","journal-title":"Respirology"},{"key":"2884_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.mayocp.2018.09.002","volume":"94","author":"I Mira-Avendano","year":"2019","unstructured":"Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB, et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases. Mayo Clin Proc. 2019;94:309\u201325. https:\/\/doi.org\/10.1016\/j.mayocp.2018.09.002.","journal-title":"Mayo Clin Proc"},{"key":"2884_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431\u201340. https:\/\/doi.org\/10.1164\/rccm.201006-0894CI.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","volume":"158","author":"G Raghu","year":"2013","unstructured":"Raghu G. Treatment of idiopathic pulmonary fibrosis with Ambrisentan. Ann Intern Med. 2013;158:641. https:\/\/doi.org\/10.7326\/0003-4819-158-9-201305070-00003.","journal-title":"Ann Intern Med"},{"key":"2884_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/thoraxjnl-2012-202403","volume":"68","author":"L Shulgina","year":"2013","unstructured":"Shulgina L, Cahn AP, Chilvers ER, Parfrey H, Clark AB, Wilson ECF, et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial. Thorax. 2013;68:155\u201362. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-202403.","journal-title":"Thorax"},{"key":"2884_CR10","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824. https:\/\/doi.org\/10.1164\/rccm.2009-040GL.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR11","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","volume":"192","author":"G Raghu","year":"2015","unstructured":"Raghu G, Rochwerg B, Zhang Y, Garcia CAC, Azuma A, Behr J, et al. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3\u201319. https:\/\/doi.org\/10.1164\/rccm.201506-1063ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00441-016-2543-2","volume":"367","author":"L Knudsen","year":"2017","unstructured":"Knudsen L, Ruppert C, Ochs M. Tissue remodelling in pulmonary fibrosis. Cell Tissue Res. 2017;367:607\u201326. https:\/\/doi.org\/10.1007\/s00441-016-2543-2.","journal-title":"Cell Tissue Res"},{"key":"2884_CR13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(12)61144-1","volume":"380","author":"IE Fernandez","year":"2012","unstructured":"Fernandez IE, Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet. 2012;380:680\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(12)61144-1.","journal-title":"Lancet"},{"key":"2884_CR14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011;208:1339\u201350. https:\/\/doi.org\/10.1084\/jem.20110551.","journal-title":"J Exp Med"},{"key":"2884_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.matbio.2018.02.004","volume":"68\u201369","author":"S Ricard-Blum","year":"2018","unstructured":"Ricard-Blum S, Baffet G, Th\u00e9ret N. Molecular and tissue alterations of collagens in fibrosis. Matrix Biol. 2018;68\u201369:122\u201349. https:\/\/doi.org\/10.1016\/j.matbio.2018.02.004.","journal-title":"Matrix Biol"},{"key":"2884_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1183\/09031936.97.10040787","volume":"10","author":"H Furuie","year":"1997","unstructured":"Furuie H, Yamasaki H, Suga M, Ando M. Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis. Eur Respir J. 1997;10:787\u201394. https:\/\/doi.org\/10.1183\/09031936.97.10040787.","journal-title":"Eur Respir J"},{"key":"2884_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1165\/ajrcmb.18.1.2627","volume":"18","author":"A Hancock","year":"1998","unstructured":"Hancock A, Armstrong L, Gama R, Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol. 1998;18:60\u20135. https:\/\/doi.org\/10.1165\/ajrcmb.18.1.2627.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2884_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1385\/IR:30:3:339","volume":"30","author":"C Jakubzick","year":"2004","unstructured":"Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunol Res. 2004;30:339\u201350. https:\/\/doi.org\/10.1385\/IR:30:3:339.","journal-title":"Immunol Res"},{"key":"2884_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","volume":"15","author":"TA Wynn","year":"2015","unstructured":"Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15:271\u201382. https:\/\/doi.org\/10.1038\/nri3831.","journal-title":"Nat Rev Immunol"},{"key":"2884_CR20","doi-asserted-by":"publisher","first-page":"39714","DOI":"10.1038\/srep39714","volume":"6","author":"SI Chung","year":"2016","unstructured":"Chung SI, Horton JA, Ramalingam TR, White AO, Chung EJ, Hudak KE, et al. IL-13 is a therapeutic target in radiation lung injury. Sci Rep. 2016;6:39714. https:\/\/doi.org\/10.1038\/srep39714.","journal-title":"Sci Rep"},{"key":"2884_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/imcb.12235","volume":"97","author":"F Puttur","year":"2019","unstructured":"Puttur F, Gregory LG, Lloyd CM. Airway macrophages as the guardians of tissue repair in the lung. Immunol Cell Biol. 2019;97:246\u201357. https:\/\/doi.org\/10.1111\/imcb.12235.","journal-title":"Immunol Cell Biol"},{"key":"2884_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/ijms18071545","volume":"18","author":"M Hesketh","year":"2017","unstructured":"Hesketh M, Sahin KB, West ZE, Murray RZ. Macrophage phenotypes regulate scar formation and chronic wound healing. Int J Mol Sci. 2017;18:1545. https:\/\/doi.org\/10.3390\/ijms18071545.","journal-title":"Int J Mol Sci"},{"key":"2884_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1136\/thoraxjnl-2015-207020","volume":"70","author":"AJ Byrne","year":"2015","unstructured":"Byrne AJ, Mathie SA, Gregory LG, Lloyd CM. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70:1189\u201396. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207020.","journal-title":"Thorax"},{"key":"2884_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cellimm.2018.01.005","volume":"330","author":"N Joshi","year":"2018","unstructured":"Joshi N, Walter JM, Misharin AV. Alveolar macrophages. Cell Immunol. 2018;330:86\u201390. https:\/\/doi.org\/10.1016\/j.cellimm.2018.01.005.","journal-title":"Cell Immunol"},{"key":"2884_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1165\/rcmb.2016-0361OC","volume":"57","author":"SL Gibbings","year":"2017","unstructured":"Gibbings SL, Thomas SM, Atif SM, McCubbrey AL, Desch AN, Danhorn T, et al. Three unique interstitial macrophages in the murine lung at steady state. Am J Respir Cell Mol Biol. 2017;57:66\u201376. https:\/\/doi.org\/10.1165\/rcmb.2016-0361OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2884_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/cimm.2000.1687","volume":"204","author":"E Song","year":"2000","unstructured":"Song E, Ouyang N, H\u00f6rbelt M, Antus B, Wang M, Exton MS. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol. 2000;204:19\u201328. https:\/\/doi.org\/10.1006\/cimm.2000.1687.","journal-title":"Cell Immunol"},{"key":"2884_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/cells12030402","volume":"12","author":"S Lib\u00f3rio-Ramos","year":"2023","unstructured":"Lib\u00f3rio-Ramos S, Barbosa-Matos C, Fernandes R, Borges-Pereira C, Costa S. Interstitial macrophages lead early stages of bleomycin-induced lung fibrosis and induce fibroblasts activation. Cells. 2023;12:402. https:\/\/doi.org\/10.3390\/cells12030402.","journal-title":"Cells"},{"key":"2884_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017;79:541\u201366. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034339.","journal-title":"Annu Rev Physiol"},{"key":"2884_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","volume":"19","author":"L Zhang","year":"2018","unstructured":"Zhang L, Wang Y, Wu G, Xiong W, Gu W, Wang C-Y. Macrophages: friend or foe in idiopathic pulmonary fibrosis? Respir Res. 2018;19:170. https:\/\/doi.org\/10.1186\/s12931-018-0864-2.","journal-title":"Respir Res"},{"key":"2884_CR30","doi-asserted-by":"publisher","first-page":"13130","DOI":"10.1038\/ncomms13130","volume":"7","author":"T Kimura","year":"2016","unstructured":"Kimura T, Nada S, Takegahara N, Okuno T, Nojima S, Kang S, et al. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals. Nat Commun. 2016;7:13130. https:\/\/doi.org\/10.1038\/ncomms13130.","journal-title":"Nat Commun"},{"key":"2884_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.molmed.2016.02.004","volume":"22","author":"AJ Byrne","year":"2016","unstructured":"Byrne AJ, Maher TM, Lloyd CM. Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease? Trends Mol Med. 2016;22:303\u201316. https:\/\/doi.org\/10.1016\/j.molmed.2016.02.004.","journal-title":"Trends Mol Med"},{"key":"2884_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159\u201375. https:\/\/doi.org\/10.1038\/nri3399.","journal-title":"Nat Rev Immunol"},{"key":"2884_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1189\/jlb.3hi1014-493r","volume":"98","author":"AD Gregory","year":"2015","unstructured":"Gregory AD, Kliment CR, Metz HE, Kim K-H, Kargl J, Agostini BA, et al. Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis. J Leukoc Biol. 2015;98:143\u201352. https:\/\/doi.org\/10.1189\/jlb.3hi1014-493r.","journal-title":"J Leukoc Biol"},{"key":"2884_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1183\/09031936.00127011","volume":"40","author":"A Takemasa","year":"2012","unstructured":"Takemasa A, Ishii Y, Fukuda T. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice. Eur Respir J. 2012;40:1475\u201382. https:\/\/doi.org\/10.1183\/09031936.00127011.","journal-title":"Eur Respir J"},{"key":"2884_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1378\/chest.07-1948","volume":"133","author":"BW Kinder","year":"2008","unstructured":"Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest. 2008;133:226\u201332. https:\/\/doi.org\/10.1378\/chest.07-1948.","journal-title":"Chest"},{"key":"2884_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature14407","volume":"522","author":"V Finisguerra","year":"2015","unstructured":"Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AAR, et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature. 2015;522:349\u201353. https:\/\/doi.org\/10.1038\/nature14407.","journal-title":"Nature"},{"key":"2884_CR37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.immuni.2017.09.012","volume":"47","author":"N Glodde","year":"2017","unstructured":"Glodde N, Bald T, van den Boorn-Konijnenberg D, Nakamura K, O\u2019Donnell JS, Szczepanski S, et al. Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy. Immunity. 2017;47:789\u2013802.e9. https:\/\/doi.org\/10.1016\/j.immuni.2017.09.012.","journal-title":"Immunity"},{"key":"2884_CR38","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.15252\/embr.201744075","volume":"18","author":"M Benkhoucha","year":"2017","unstructured":"Benkhoucha M, Molnarfi N, Kaya G, Belnoue E, Bjarnad\u00f3ttir K, Dietrich P, et al. Identification of a novel population of highly cytotoxic c-Met-expressing CD8 + T lymphocytes. EMBO Rep. 2017;18:1545\u201358. https:\/\/doi.org\/10.15252\/embr.201744075.","journal-title":"EMBO Rep"},{"key":"2884_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1010247","volume":"18","author":"K Passelli","year":"2022","unstructured":"Passelli K, Prat-Luri B, Merlot M, Goris M, Mazzone M, Tacchini-Cottier F. The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis. PLoS Pathog. 2022;18:1\u201324. https:\/\/doi.org\/10.1371\/journal.ppat.1010247.","journal-title":"PLoS Pathog"},{"key":"2884_CR40","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/ecco-jcc\/jjaa121","volume":"14","author":"M Stakenborg","year":"2020","unstructured":"Stakenborg M, Verstockt B, Meroni E, Goverse G, De Simone V, Verstockt S, et al. Neutrophilic HGF-MET signalling exacerbates intestinal inflammation. J Crohn\u2019s Colitis. 2020;14:1748\u201358. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa121.","journal-title":"J Crohn\u2019s Colitis"},{"key":"2884_CR41","doi-asserted-by":"publisher","first-page":"e0212911","DOI":"10.1371\/journal.pone.0212911","volume":"14","author":"S Gori","year":"2019","unstructured":"Gori S, Alcain J, Vanzulli S, Moreno Ayala MA, Candolfi M, Jancic C, et al. Acetylcholine-treated murine dendritic cells promote inflammatory lung injury. PLoS One. 2019;14:e0212911. https:\/\/doi.org\/10.1371\/journal.pone.0212911.","journal-title":"PLoS One"},{"key":"2884_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467\u201370. https:\/\/doi.org\/10.1136\/jcp.41.4.467.","journal-title":"J Clin Pathol"},{"key":"2884_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"2884_CR44","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","volume":"199","author":"PA Reyfman","year":"2019","unstructured":"Reyfman PA, Walter JM, Joshi N, Anekalla KR, McQuattie-Pimentel AC, Chiu S, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199:1517\u201336. https:\/\/doi.org\/10.1164\/rccm.201712-2410OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","volume":"40","author":"A Moeller","year":"2008","unstructured":"Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40:362\u201382. https:\/\/doi.org\/10.1016\/j.biocel.2007.08.011.","journal-title":"Int J Biochem Cell Biol"},{"key":"2884_CR46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/MCP.0b013e328349ac2b","volume":"17","author":"MA Mouratis","year":"2011","unstructured":"Mouratis MA, Aidinis V. Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med. 2011;17:355\u201361. https:\/\/doi.org\/10.1097\/MCP.0b013e328349ac2b.","journal-title":"Curr Opin Pulm Med"},{"key":"2884_CR47","doi-asserted-by":"publisher","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","volume":"294","author":"BB Moore","year":"2008","unstructured":"Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Cell Mol Physiol. 2008;294:L152\u201360. https:\/\/doi.org\/10.1152\/ajplung.00313.2007.","journal-title":"Am J Physiol Cell Mol Physiol"},{"key":"2884_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.02135","volume":"11","author":"N Nishikoba","year":"2020","unstructured":"Nishikoba N, Kumagai K, Kanmura S, Nakamura Y, Ono M, Eguchi H, et al. HGF-MET signaling shifts M1 macrophages toward an M2-like phenotype through PI3K-mediated induction of arginase-1 expression. Front Immunol. 2020;11:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2020.02135.","journal-title":"Front Immunol"},{"key":"2884_CR49","doi-asserted-by":"publisher","first-page":"289S","DOI":"10.1378\/chest.122.6_suppl.289S","volume":"122","author":"PM Krein","year":"2002","unstructured":"Krein PM, Winston BW. Roles for insulin-like growth factor I and transforming growth factor-\u03b2 in fibrotic lung disease. Chest. 2002;122:289S\u2013293S. https:\/\/doi.org\/10.1378\/chest.122.6_suppl.289S.","journal-title":"Chest"},{"key":"2884_CR50","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/mt.2015.66","volume":"23","author":"J Tonkin","year":"2015","unstructured":"Tonkin J, Temmerman L, Sampson RD, Gallego-Colon E, Barberi L, Bilbao D, et al. Monocyte\/macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization. Mol Ther. 2015;23:1189\u2013200. https:\/\/doi.org\/10.1038\/mt.2015.66.","journal-title":"Mol Ther"},{"key":"2884_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/labinvest.2012.162","volume":"93","author":"MP Alfaro","year":"2013","unstructured":"Alfaro MP, Deskins DL, Wallus M, DasGupta J, Davidson JM, Nanney LB, et al. A physiological role for connective tissue growth factor in early wound healing. Lab Investig. 2013;93:81\u201395. https:\/\/doi.org\/10.1038\/labinvest.2012.162.","journal-title":"Lab Investig"},{"key":"2884_CR52","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1165\/rcmb.2007-0364OC","volume":"40","author":"RC Russo","year":"2009","unstructured":"Russo RC, Guabiraba R, Garcia CC, Barcelos LS, Roff\u00ea E, Souza ALS, et al. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol. 2009;40:410\u201321. https:\/\/doi.org\/10.1165\/rcmb.2007-0364OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2884_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/ijms21010227","volume":"21","author":"I Cheng","year":"2019","unstructured":"Cheng I, Liu C, Lin J, Hsu T-W, Hsu J, Li AF-Y, et al. Particulate matter increases the severity of bleomycin-induced pulmonary fibrosis through KC-mediated neutrophil chemotaxis. Int J Mol Sci. 2019;21:227. https:\/\/doi.org\/10.3390\/ijms21010227.","journal-title":"Int J Mol Sci"},{"key":"2884_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1164\/rccm.200609-1279OC","volume":"176","author":"CP Baran","year":"2007","unstructured":"Baran CP, Opalek JM, McMaken S, Newland CA, O\u2019Brien JM, Hunter MG, et al. Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:78\u201389. https:\/\/doi.org\/10.1164\/rccm.200609-1279OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR55","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/path.1667","volume":"204","author":"T Okuma","year":"2004","unstructured":"Okuma T, Terasaki Y, Kaikita K, Kobayashi H, Kuziel WA, Kawasuji M, et al. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J Pathol. 2004;204:594\u2013604. https:\/\/doi.org\/10.1002\/path.1667.","journal-title":"J Pathol"},{"key":"2884_CR56","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0002-9440(10)61235-7","volume":"167","author":"F Huaux","year":"2005","unstructured":"Huaux F, Gharaee-Kermani M, Liu T, Morel V, McGarry B, Ullenbruch M, et al. Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis. Am J Pathol. 2005;167:1485\u201396. https:\/\/doi.org\/10.1016\/S0002-9440(10)61235-7.","journal-title":"Am J Pathol"},{"key":"2884_CR57","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.4049\/jimmunol.1201043","volume":"190","author":"VJ Craig","year":"2013","unstructured":"Craig VJ, Quintero PA, Fyfe SE, Patel AS, Knolle MD, Kobzik L, et al. Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol. 2013;190:4283\u201396. https:\/\/doi.org\/10.4049\/jimmunol.1201043.","journal-title":"J Immunol"},{"key":"2884_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1465-9921-14-102","volume":"14","author":"CF Hung","year":"2013","unstructured":"Hung CF, Rohani MG, Lee S, Chen P, Schnapp LM. Role of IGF-1 pathway in lung fibroblast activation. Respir Res. 2013;14:102. https:\/\/doi.org\/10.1186\/1465-9921-14-102.","journal-title":"Respir Res"},{"key":"2884_CR59","doi-asserted-by":"publisher","first-page":"210169","DOI":"10.1183\/16000617.0169-2021","volume":"31","author":"M Hamblin","year":"2022","unstructured":"Hamblin M, Prosch H, Va\u0161\u00e1kov\u00e1 M. Diagnosis, course and management of hypersensitivity pneumonitis. Eur Respir Rev. 2022;31:210169. https:\/\/doi.org\/10.1183\/16000617.0169-2021.","journal-title":"Eur Respir Rev"},{"key":"2884_CR60","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","volume":"186","author":"M Selman","year":"2012","unstructured":"Selman M, Pardo A, King TE. Hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2012;186:314\u201324. https:\/\/doi.org\/10.1164\/rccm.201203-0513CI.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR61","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","volume":"202","author":"G Raghu","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of hypersensitivity pneumonitis in adults: an official ATS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202:e36\u201369. https:\/\/doi.org\/10.1164\/rccm.202005-2032ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"2884_CR62","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.chest.2021.03.067","volume":"160","author":"ER Fern\u00e1ndez P\u00e9rez","year":"2021","unstructured":"Fern\u00e1ndez P\u00e9rez ER, Travis WD, Lynch DA, Brown KK, Johannson KA, Selman M, et al. Executive summary. Chest. 2021;160:595\u2013615. https:\/\/doi.org\/10.1016\/j.chest.2021.03.067.","journal-title":"Chest"},{"key":"2884_CR63","doi-asserted-by":"publisher","first-page":"190029","DOI":"10.1183\/16000617.0029-2019","volume":"28","author":"T Yanagihara","year":"2019","unstructured":"Yanagihara T, Sato S, Upagupta C, Kolb M. What have we learned from basic science studies on idiopathic pulmonary fibrosis? Eur Respir Rev. 2019;28:190029. https:\/\/doi.org\/10.1183\/16000617.0029-2019.","journal-title":"Eur Respir Rev"},{"key":"2884_CR64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1165\/rcmb.2021-0418OC","volume":"67","author":"APM Serezani","year":"2022","unstructured":"Serezani APM, Pascoalino BD, Bazzano JMR, Vowell KN, Tanjore H, Taylor CJ, et al. Multiplatform single-cell analysis identifies immune cell types enhanced in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2022;67:50\u201360. https:\/\/doi.org\/10.1165\/rcmb.2021-0418OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2884_CR65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/MCP.0000000000000698","volume":"26","author":"T Yanagihara","year":"2020","unstructured":"Yanagihara T, Inoue Y. Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases. Curr Opin Pulm Med. 2020;26:507\u201317. https:\/\/doi.org\/10.1097\/MCP.0000000000000698.","journal-title":"Curr Opin Pulm Med"},{"key":"2884_CR66","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450\u201362. https:\/\/doi.org\/10.1016\/j.immuni.2016.02.015.","journal-title":"Immunity"},{"key":"2884_CR67","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse C, Tabib T, Sembrat J, Buschur KL, Bittar HT, Valenzi E, et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur Respir J. 2019;54:1802441. https:\/\/doi.org\/10.1183\/13993003.02441-2018.","journal-title":"Eur Respir J"},{"key":"2884_CR68","doi-asserted-by":"publisher","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","volume":"6","author":"TS Adams","year":"2020","unstructured":"Adams TS, Schupp JC, Poli S, Ayaub EA, Neumark N, Ahangari F, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv. 2020;6:eaba1983. https:\/\/doi.org\/10.1126\/sciadv.aba1983.","journal-title":"Sci Adv"},{"key":"2884_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aar8356","volume":"10","author":"LJ Celada","year":"2018","unstructured":"Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, et al. PD-1 up-regulation on CD4 + T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production. Sci Transl Med. 2018;10:1\u201315. https:\/\/doi.org\/10.1126\/scitranslmed.aar8356.","journal-title":"Sci Transl Med"},{"key":"2884_CR70","doi-asserted-by":"publisher","first-page":"107525","DOI":"10.1016\/j.intimp.2021.107525","volume":"95","author":"M d\u2019Alessandro","year":"2021","unstructured":"d\u2019Alessandro M, Bergantini L, Cameli P, Fanetti M, Alderighi L, Armati M, et al. Immunologic responses to antifibrotic treatment in IPF patients. Int Immunopharmacol. 2021;95:107525. https:\/\/doi.org\/10.1016\/j.intimp.2021.107525.","journal-title":"Int Immunopharmacol"},{"key":"2884_CR71","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1165\/ajrcmb.16.4.9115749","volume":"16","author":"T Sakai","year":"1997","unstructured":"Sakai T, Satoh K, Matsushima K, Shindo S, Abe S, Abe T, et al. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am J Respir Cell Mol Biol. 1997;16:388\u201397. https:\/\/doi.org\/10.1165\/ajrcmb.16.4.9115749.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2884_CR72","doi-asserted-by":"publisher","first-page":"260","DOI":"10.20452\/pamw.2784","volume":"125","author":"G Przybylski","year":"2015","unstructured":"Przybylski G, Chorostowska-Wynimko J, Dyczek A, Wedrowska E, Jankowski M, Szpechci\u0144ski A, et al. Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases. Pol Arch Med Wewn. 2015;125:260\u201371. https:\/\/doi.org\/10.20452\/pamw.2784.","journal-title":"Pol Arch Med Wewn"},{"key":"2884_CR73","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0954-6111(97)90083-4","volume":"91","author":"S Hojo","year":"1997","unstructured":"Hojo S, Fujita J, Yoshinouchi T, Yamanouchi H, Kamei T, Yamadori I, et al. Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis. Respir Med. 1997;91:511\u20136. https:\/\/doi.org\/10.1016\/S0954-6111(97)90083-4.","journal-title":"Respir Med"},{"key":"2884_CR74","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0954-6111(98)90108-1","volume":"92","author":"H Yamanouchi","year":"1998","unstructured":"Yamanouchi H, Fujita J, Yoshinouchi T, Hojo S, Kamei T, Yamadori I, et al. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. Respir Med. 1998;92:273\u20138. https:\/\/doi.org\/10.1016\/S0954-6111(98)90108-1.","journal-title":"Respir Med"},{"key":"2884_CR75","doi-asserted-by":"publisher","first-page":"308","DOI":"10.32074\/1591-951X-920","volume":"115","author":"L Melocchi","year":"2023","unstructured":"Melocchi L, Cervi G, Sartori G, Gandolfi L, Jocoll\u00e9 G, Cavazza A, et al. Up-regulation by overexpression of c-MET in fibroblastic foci of usual interstitial pneumonia. Pathologica. 2023;115:308\u201317. https:\/\/doi.org\/10.32074\/1591-951X-920.","journal-title":"Pathologica"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02884-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T09:04:49Z","timestamp":1719047089000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02884-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02884-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,22]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments followed the EU-adopted regulations (Directive 2010\/63\/EU). Animal ethics approval has been consented by Dire\u00e7\u00e3o Geral de Alimenta\u00e7\u00e3o e Veterin\u00e1ria (DGAV, 003671) and conducted according to the guidelines sanctioned by the DGAV. Human study involving samples from patients followed at Hospital de S\u00e3o Jo\u00e3o, Porto, Portugal, was approved by the Ethics Committee of Hospital de S\u00e3o Jo\u00e3o (CES 72-12).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}